Our findings, show that FMRP is expressed in both the nucleus and cytoplasm of breast cancer cells and that different levels of FMRP correlate with specific metastatic sites suggesting a possible role as prognostic factor for site-specific metastasis. This evidence concerns the gene FMR1 and breast carcinoma.